Clonal gammopathies and allogeneic stem cell transplantation [3]

Bone Marrow Transplantation

Volumn 41, Issue 3, 2008, Pages 317-

  Sora F ^a   Laurenti, L ^a   Chiusolo, P ^a   De Matteis, S ^a   Leone, G ^a   Sica, S ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS; GAMMOPATHY; HEPATITIS B; HUMAN; INFECTION RATE; LETTER; LYMPHOPROLIFERATIVE DISEASE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; VIREMIA; VIRUS REACTIVATION;

EPSTEIN-BARR VIRUS INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MONOCLONAL GAMMOPATHIES, BENIGN; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION;

EID: 39349090079     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705916     Document Type: Letter

References (6)

1. Lim ZY, Ingram W, Brand R, Akthari M, Milojkovic D, Ho AY et al. Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and improved overall survival. Bone Marrow Transplant 2007; 40: 747-752.
2. Babel N, Schwarzmann F, Pruss A, Volk HD, Reinke P. Monoclonal gammopathy of undetermined significance (MGUS) is associated with an increased frequency of Epstein-Barr virus (EBV) latently infected B lymphocytes in long-term renal transplant patients. Clin Transplant 2005; 19: 644-652.
3. Tsai DE, Aqui NA, Tomaszewski JE, Olthoff KM, Ahya VN, Kotloff RM et al. Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder. Liver Transpl Surg 1996, 2: 375-382.
4. Badley AD, Portela DF, Patel R, Kyle RA, Habermann TM, Strickler JG et al. Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced post-transplant lymphoproliferative disorder. Transplant Proc 2004; 36: 2679-2682.
5. Cohen J, Gandhi M, Naik P, Cubitt D, Rao K, Thaker U et al. Increased incidence of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioning. Br J Haematol 2005; 129: 229-239.
6. Scheinberg P, Fischer SH, Li L, Nunez O, Wu CO, Sloand EM et al. Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood 2007; 109: 3219-3224.